Multi-drug resistant E.coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies - three cases including one death

Canadian Journal of Urology

Volumn 17, Issue 2, 2010, Pages 5135-5137

  Carlson, William H ^a   Bell, David G ^a   Lawen, Joseph G ^a   Rendon, Ricardo A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antibiotic resistance; Biopsy; Prostate; Urosepsis

Indexed keywords

ANTIINFECTIVE AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CASE REPORT; DRUG EFFECT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FATALITY; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NEEDLE BIOPSY; PATHOLOGY; PHYSICAL EXAMINATION; PHYSICIAN; PROSTATE; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BIOPSY, NEEDLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PHYSICIANS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77956202768     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Raajimakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schroder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based program. Urology 2002;60(5):826-830.
3. Rodriguez L, Terris M. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of literature. J Urol 1998;160(6 Pt 1):2115-2120.
4. Enlund A, Varenhorst E. Morbidity of ultrasound-guided trans-rectal core biopsy of the prostate without prophylactic antibiotic therapy: a prospective study in 415 cases. Br J Urol 1997;79(5):777-780.
5. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graham E, Echols RM, Whalen E, Kowalsky SF. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52(4):552-558.
6. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000;85(6):682-685.
7. Shandera K, Thibault G, Deshon G. Variability in patient preparation for prostate biopsy among American urologists. Urology 1998;52(4):644-646.
8. Miura T, Tanaka K, Shigemura K, Nakano Y, Takenaka A, Fujisawa M. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Int J Urol 2008;15(5):457-459.
9. Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, Colon I. The incidence of fluoroquinolone resistant infections after prostate biopsy - are fluoroquinolones still effective prophylaxis? J Urol 2008;179(3):952-955.
10. Young J, Liss M, Szabo R. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. J Urol 2008;74(2):332-338.
11. Kamdar C, Mooppan UM, Gulmi FA, Kim H. Multi-drugresistant bacteremia after transrectal ultrasound guided prostate biopsies in hospital employees and their relatives. J Urol 2008;72(1):34-36.
12. Weber B, Saliken J, Jadavji T, Gray RR, Moore R. A near-fatal case of sepsis with an antibiotic-resistant organism complicating a routine transrectal prostate biopsy in a health care worker. CUAJ 2008;2(5):543-545.
13. Shigehara K, Uchibayashi T, Maeda E, Namiki M. Detection of drug-resistant Escherichia coli in patients with complicated cystitis: analysis of risk factors. Int J Urol 2009;16(10):808-812.
14. Lautenbach E, Metlay JP, Weiner MG, Biker WB, Tolomeo P, Mao X, Nachamkin I, Fishman NO. Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol 2009;30(1):18-24.
15. Jones R. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001;119(2 Suppl):397-404.
16. Solberg C. Spread of Staphylococcus aureus in hospitals: causes and prevention. Scand J Infect Dis 2000;32(6):587-595.
17. Yoshitsugu N, Miyabi I et al. Rectal swab cultures can assess for alternations in microbial flora; rectal colonization of fluoroquinolone resistant Escherichia coli among transrectal ultrasonography guided prostate biopsy patients. J Urol 2009; 181(4 Suppl):66.